Mediwatch PLC Extension of deadline under Rule 2.6(c) (2095T)
16 November 2013 - 3:51AM
UK Regulatory
TIDMMDW
RNS Number : 2095T
Mediwatch PLC
15 November 2013
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN
PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD
CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH
JURISDICTION
THIS ANNOUNCEMENT IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO
MAKE AN OFFER UNDER RULE 2.7 OF THE CITY CODE ON TAKEOVERS AND
MERGERS (THE "CODE") AND THERE CAN BE NO CERTAINTY THAT ANY OFFER
WILL BE MADE
Announcement by the Board of Mediwatch plc ("Mediwatch")
15 November 2013
Extension of deadline under Rule 2.6(c) of the Code
In accordance with Rule 2.6(a) of the Code, Laborie was
required, by not later than 5.00 p.m. on 15 November 2013, to
either announce a firm intention to make an offer for Mediwatch in
accordance with Rule 2.7 of the Code or announce it does not intend
to make an offer, unless the Takeover Panel (the "Panel") consented
to an extension of the deadline. The Panel has consented to an
extension of this deadline up to 5.00 p.m. on 18 November 2013, to
enable the parties to conclude their on-going discussions regarding
a possible offer for Mediwatch. The revised deadline will only be
extended, if requested, with the consent of the Panel in accordance
with Rule 2.6(c) of the Code.
Discussions are at an advanced stage but there is no certainty
that at the end of this period, an offer for Mediwatch will be
made.
A further announcement will be made in due course.
A copy of this announcement will be available on Mediwatch's
website (www.mediwatch.com). The content of the website referred to
in this announcement is not incorporated into and does not form
part of this announcement.
Enquiries:
Mediwatch plc Tel: +44 (0)1788
Dr Philip Stimpson, Chief Executive / Mark 547 888
Hughes, Chief Financial Officer
SP Angel Corporate Finance LLP Tel: +44 (0) 20
Financial Adviser, Nominated Adviser and 3463 2260
Broker to Mediwatch
David Facey / Katy Birkin / Liz Yong
-----------------
Important Notice
This announcement is for information purposes only, and is not
intended to and does not constitute, or form part of, an offer,
invitation or the solicitation of an offer to purchase, otherwise
acquire, subscribe for, sell or otherwise dispose of any
securities, or the solicitation of any vote or approval in any
jurisdiction.
SP Angel Corporate Finance LLP, which is authorised and
regulated by the Financial Conduct Authority in the United Kingdom,
is acting exclusively as financial adviser to Mediwatch and no one
else in connection with the matters described in this announcement,
and will not be responsible for anyone other than Mediwatch for
providing the protections afforded to clients of SP Angel Corporate
Finance LLP nor for providing advice in relation to the matters
referred to in this announcement. Neither SP Angel Corporate
Finance LLP nor any of its affiliates, partners or employees owes
or accepts any duty, liability or responsibility whatsoever
(whether direct or indirect, whether in contract, in tort, under
statute or otherwise) to any person who is not a client of SP Angel
Corporate Finance LLP in connection with this announcement, any
statement contained herein or otherwise.
Disclosure requirements of the Takeover Code (the "Code")
Under Rule 8.3(a) of the Code, any person who is interested in
1% or more of any class of relevant securities of an offeree
company or of any securities exchange offeror (being any offeror
other than an offeror in respect of which it has been announced
that its offer is, or is likely to be, solely in cash) must make an
Opening Position Disclosure following the commencement of the offer
period and, if later, following the announcement in which any
securities exchange offeror is first identified. An Opening
Position Disclosure must contain details of the person's interests
and short positions in, and rights to subscribe for, any relevant
securities of each of (i) the offeree company and (ii) any
securities exchange offeror(s). An Opening Position Disclosure by a
person to whom Rule 8.3(a) applies must be made by no later than
3.30 pm (London time) on the 10th business day following the
commencement of the offer period and, if appropriate, by no later
than 3.30 pm (London time) on the 10th business day following the
announcement in which any securities exchange offeror is first
identified. Relevant persons who deal in the relevant securities of
the offeree company or of a securities exchange offeror prior to
the deadline for making an Opening Position Disclosure must instead
make a Dealing Disclosure.
Under Rule 8.3(b) of the Code, any person who is, or becomes,
interested in 1% or more of any class of relevant securities of the
offeree company or of any securities exchange offeror must make a
Dealing Disclosure if the person deals in any relevant securities
of the offeree company or of any securities exchange offeror. A
Dealing Disclosure must contain details of the dealing concerned
and of the person's interests and short positions in, and rights to
subscribe for, any relevant securities of each of (i) the offeree
company and (ii) any securities exchange offeror, save to the
extent that these details have previously been disclosed under Rule
8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies
must be made by no later than 3.30 pm (London time) on the business
day following the date of the relevant dealing.
If two or more persons act together pursuant to an agreement or
understanding, whether formal or informal, to acquire or control an
interest in relevant securities of an offeree company or a
securities exchange offeror, they will be deemed to be a single
person for the purpose of Rule 8.3.
Opening Position Disclosures must also be made by the offeree
company and by any offeror and Dealing Disclosures must also be
made by the offeree company, by any offeror and by any persons
acting in concert with any of them (see Rules 8.1, 8.2 and
8.4).
Details of the offeree and offeror companies in respect of whose
relevant securities Opening Position Disclosures and Dealing
Disclosures must be made can be found in the Disclosure Table on
the Takeover Panel's website at www.thetakeoverpanel.org.uk,
including details of the number of relevant securities in issue,
when the offer period commenced and when any offeror was first
identified. You should contact the Panel's Market Surveillance Unit
on +44 (0)20 7638 0129 if you are in any doubt as to whether you
are required to make an Opening Position Disclosure or a Dealing
Disclosure.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCNKPDQABDDFDD
Mediwatch (LSE:MDW)
Historical Stock Chart
From May 2024 to Jun 2024
Mediwatch (LSE:MDW)
Historical Stock Chart
From Jun 2023 to Jun 2024